drugset / Trial / NCT04774887

ERADICATING CERVICAL CANCER IN KENYA

NCT04774887

NaSingle-groupOpen-labelPrevention

Summary

This is a study of a strategy designed to 1) increase cervical cancer screening using a community-based approach, and 2) determine the efficacy of HPV vaccination in a region of Kenya where half of all children are chronically exposed to aflatoxin.

Timeline

Start
2021-11-13
Primary completion
2023-10-18
Completion
2023-10-18

Drugs

EvaluationDrugModalityDoseRoute
Subject Varivax Vaccine